Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

#18-1795 Delisting of Instrument issued by Morgan Stanley & Co. International plc

After the end of trading on October 04, 2018, 1 instrument issued by Morgan Stanley & Co. International plc will be delisted from ETP Sweden.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 10 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a

Elekta wins user-centered product design award for its MR-linac, Elekta Unity

Award affirms Elekta’s and DCA’s ability to innovate new technology while remaining focused on physician and patient needsPHILADELPHIA, USA, October 3, 2018 – Elekta (EKTA-B.ST) and DCA Design International Ltd have won the prestigious Human Factors and Ergonomics Society (HFES) Stanley H. Caplan User-Centered Product Design Award 2018 for Elekta Unity, Elekta’s MR-linac. Elekta Unity combines high-field 1.5 Tesla MR imaging, precision radiation therapy and intelligent software, giving clinicians the previously unattainable ability to see what they treat in real time. This U.S.-based award

BioArctic receives European patent protection for a medical device for treatment of patients with Complete Spinal Cord Injury

Stockholm, Sweden, October 3, 2018 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the European Patent Office (EPO) has issued a decision to grant the company’s patent application in Europe, EP12815796.3, for a medical device, which is one of the main components in the product candidate SC0806. The product candidate is a combination of a medical device (implant) and a medicinal product (FGF1) for patients with complete spinal cord injury. The decision states that the European patent, EP 2 787 900 B1, will enter into force on October 24, 2018. The patent will provide

Tokmanni Group Corporation: Members of Tokmanni Group's Nomination Board

Tokmanni Group Corporation     Stock exhange release     3 October 2018 at 3.25 pm EESTRepresentatives of the four largest shareholders registered in Tokmanni Group's shareholder register as of September 1, 2018 are elected to the Shareholders' Nomination Board along with the Chairman of the Board of Directors, Seppo Saastamoinen, as an expert member. The Nomination Board is responsible for preparing proposals covering the composition of the Board of Directors and remuneration of the Board members to the next Annual General Meeting. The four largest shareholders have nominated

#18-1794 Listing of Knock out warrants issued by Vontobel Financial Products GmbH

As from October 04, 2018, 6 Knock out warrants issued by Vontobel Financial Products GmbH will be listed on ETP Finland and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Finland Oy.Issuer: Vontobel Financial Products GmbH Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from October 04, 2018 and forward or until time for knock out event Market Maker: Bank Vontobel Europe AG Underlying: DAX 30 Index ICE Brent Crude Oil Futures Nokia Oyj Current values of strike and barrier

#18-1793 Listing of Mini futures issued by Vontobel Financial Products GmbH

As from October 04, 2018, 2 Mini futures issued by Vontobel Financial Products GmbH will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Vontobel Financial Products GmbH Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from October 04, 2018 and forward or until time for knock out event Market Maker: Bank Vontobel Europe AG Underlying: ICE Brent Crude Oil Futures OMXS30 index Current values of strike and barrier can be found at: [ NGM

Industrial durability for the needs of transport and construction

Along with the inauguration of the new birch plywood mill in Pärnu, Estonia, Metsä Wood has published a new image series called “Industrial Durability”. The images visualise the value of birch plywood in the urban end-use context.The growth of urbanization and e-commerce are driving demand for birch plywood. Construction is increasing mainly in cities, and the industry needs durable and light plywood for concrete formwork. E-commerce is increasing the number of delivery vans transporting goods in urban areas. The floors and walls of these vans are made of large plywood panels. Also, the

#18-1792 Listing of Knock out warrants issued by BNP Paribas Issuance B.V.

As from October 04, 2018, 6 Knock out warrants issued by BNP Paribas Issuance B.V. will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: BNP Paribas Issuance B.V. Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from October 04, 2018 and forward or until time for knock out event Market Maker: BNP Paribas Arbitrage SNC Underlying: ICE Brent Crude Oil Futures OMXS30 index Current values of strike and barrier can be found at: [ NGM

#18-1791 Listing of Mini futures issued by BNP Paribas Issuance B.V.

As from October 04, 2018, 9 Mini futures issued by BNP Paribas Issuance B.V. will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: BNP Paribas Issuance B.V. Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from October 04, 2018 and forward or until time for knock out event Market Maker: BNP Paribas Arbitrage SNC Underlying: EUR/SEK Exchange Rate EUR/USD Exchange Rate USD/JPY Exchange Rate USD/SEK Exchange Rate COMEX Copper Futures

Offer by the Cabonline Group for Taksi Helsinki

The Cabonline Group has submitted an offer to acquire the assets of Taksi Helsinki Oy. The Board of Taksi Helsinki has now decided to give the company’s Extraordinary General Meeting on 24th of October the opportunity to consider the offer.Taksi Helsinki is Finland’s largest taxi dispatch company, with the Cabonline Group currently owning 7.5% of the company via a wholly-owned subsidiary. Taksi Helsinki’s operation includes approximately 1,335 vehicles, of which 133 belong to Cabonline. In total, the company undertakes over seven million journeys each year.  “Through the acquisition of

Metsä Wood’s birch plywood mill inaugurated in Pärnu

Metsä Group press release 3 October 2018The new birch plywood mill of Metsä Wood, the Wood Products Industry segment of Metsä Group, was inaugurated in Pärnu today, 3 October 2018. Formal addresses were given at the event by Rene Tammist, Minister of Entrepreneurship and Information Technology of Estonia, and Ilkka Hämälä, President and CEO of Metsä Group. The investment in the birch plywood mill in Pärnu is worth EUR 55 million. It enables Metsä Wood to respond to the growing demand for birch plywood in the global market. For Metsä Wood, the Pärnu mill is a strategically important

Swedavia passenger statistics for September 2018

The number of passengers who flew to or from Swedavia’s ten airports in September 2018 was 3,766,000 which is a 2 per cent decrease compared to the same period last year. International passenger volume was essentially unchanged, with 2,577,000 passengers, while domestic volume was down 7 per cent to 1,189,000. September showed a decrease in passenger volume at Swedavia’s airports. At Stockholm Arlanda Airport, the number of passengers was down 1 per cent to 2,387,000 passengers. Passenger volume at Göteborg Landvetter Airport was down 3 per cent to 634,000. The number of domestic

ExpreS2ion’s proprietary platform used for successful production of another transmission blocking malaria vaccine candidate

ExpreS2ion Biotech Holding AB and its affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announce that a recently published scientific article in Nature Communications on the Pfs48/45 malaria vaccine candidate adds further evidence to support that the ExpreS2 platform is an excellent tool for producing transmission blocking malaria vaccines. This is a promising class of next generation vaccines, which is developed with substantial support from the Bill and Melinda Gates foundation.The article is cowritten by researchers at the University of Oxford and ExpreS2ion, who are also engaged

CELLINK and partners have been granted project financing from EU totaling €5,700,000 for the Giotto project. CELLINKs portion of the grant is €300,000

The project aims to develop three different medical devices designed to treat specific osteoporotic fractures through a synergistic convergence of smart nanomaterials, 3D fabrication technologies and targeted cell activation. The overall objective of GIOTTO is to implement solutions and tools to enhance active ageing thereby mitigating the economic burden to health systems and bringing within grasp benefits for the old. CELLINK has been awarded project funding from the EU for the project “GIOTTO”- Active AgeIng and Osteoporosis: The next challenge for smart nanobiomaterials and 3D

ANSYS and Granta Design Collaborate to Empower Additive Manufacturing

Combination of simulation and materials information management provides vital insights to reduce trial and errorPITTSBURGH, October 3, 2018 – Engineers and scientists can now effectively manage and leverage materials information for additive manufacturing (AM) thanks to a new partnership between ANSYS  (NASDAQ: ANSS) and Granta Design . Accurate, reliable and traceable materials information is crucial for additive manufacturing. The combination of ANSYS’ powerful simulation for metal powder bed AM with Granta’s existing GRANTA MI:

Notification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock Investment Management (UK) Limited’s holding in Wärtsilä

Wärtsilä Corporation Stock exchange release 3 October 2018 at 2.20 pm EESTBlackRock, Inc. has informed Wärtsilä Corporation that the number of Wärtsilä’s shares and voting rights held by BlackRock Investment Management (UK) Limited crossed above the 5% disclosure limit on 2 October 2018. Following the transaction BlackRock Investment Management (UK) Limited owns 5.04% of Wärtsilä’s shares and voting rights, while its total holding in Wärtsilä Corporation corresponds to 5.16%. The total number of shares held by BlackRock, Inc. and its funds subject to the notification is 8.48% of Wärtsilä’s

NetEnt selected as supplier to ATG for the re-regulated market in Sweden

NetEnt, leading provider of digital casino solutions, has entered into an agreement to supply its award-winning online casino games to Sweden’s main horse racing operator AB Trav och Galopp (ATG), as the new Swedish gambling law takes effect on January 1st, 2019.ATG was founded in 1974 and will be one of Sweden’s largest gaming operators on the re-regulated market. The company is owned by the Swedish Trotting Association and the Swedish Jockey Club, with the aim of guaranteeing long-term financial stability for trotting and thoroughbred racing. On June 7th, 2018, the Swedish parliament,

Clinical outcome for Episealer® to be presented at the annual meeting of the Danish Orthopaedic Society (DOS) in Copenhagen

Episurf Medical (Nasdaq: EPIS B) today announces that the scientific abstract “Clinical results of an individualized mini-metal implant for focal cartilage lesions in the knee” by Prof. Martin Lind et al. will be presented at the DOS congress in Copenhagen, Denmark, which will take place on October 24 - 26, 2018. The clinical outcome for patients undergoing treatment for femoral chondral defects using the individualised mini-metal implant Episealer® is presented. The abstract shows excellent early clinical results from the treatment of focal symptomatic cartilage lesions on the

Basware releases Q3 2018 Interim Report on Wednesday, October 17, 2018 at 08.45am EET

Basware Corporation releases its interim report for the period July 1-September 30, 2018 on Wednesday, October 17, 2018 at 08.45am EET. The report will be available on the company’s investor website at  investors.basware.com/en  after publishing.  Basware arranges a briefing for analysts and press, where CEO Vesa Tykkyläinen and CFO Niclas Rosenlew will comment on the events and financial performance of the third quarter.  Time:  Wednesday, October 17, 2018 at 1 pm EET / 11 am BST / 6 am EDTPlace:  Glo Hotel Kluuvi (Kluuvikatu 4, 2nd floor), Helsinki, Finland Audiocast and

2cureX German subsidiary receive contribution for the development of IndiTreat® tests in immuno-oncology

2cureX AB’s German subsidiary 2cureX GmbH (“2cureX”) has received funding from the German Federal Ministry of Education and Research to develop an IndiTreat® test for individualizing immuno-oncological treatment.2cureX has received a grant of 810,000 EUR from the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) to adapt the IndiTreat® to individualized immuno-oncology treatment. The project is run in collaboration with the University Medical Center Hamburg-Eppendorf (Universitätsklinikum Hamburg-Eppendorf, UKE). 2cureX is co-financing the

The Nobel Prize in Chemistry 2018 – They harnessed the power of evolution

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2018 with one half to Frances H. Arnold, California Institute of Technology, Pasadena, USA “for the directed evolution of enzymes” and the other half jointly to George P. Smith, University of Missouri, Columbia, USA and Sir Gregory P. Winter, MRC Laboratory of Molecular Biology, Cambridge, UK “for the phage display of peptides and antibodies”.   The power of evolution is revealed through the diversity of life. The 2018 Nobel Laureates in Chemistry have taken control of evolution and

Improved metabolic control may reverse nerve damage in the feet caused by diabetes.

For the first time ever, it has been shown that improved HbA1c (long-term blood sugar) is linked with improved tactile perception of feet in diabetic patients. The discovery was made in a study to evaluate the Multi-Frequency Vibrometry method and the VibroSense Meter® instrument. The result is reported by Dr. Eero Lindholm in a poster presentation at the EASD Diabetes Congress in Berlin on October 1-5, 2018. VibroSense Dynamics participates as exhibitor at stand 4J05.Dr. Eero Lindholm has studied two matched groups of diabetes patients that differ in their metabolic control of HbA1c for a

Peptonic Medical receives order from Orion Pharma worth over one million SEK

Stockholm 3rd October 2018 - Peptonic Medical AB (publ) (’Peptonic’) or (’Company’) today announced that it has received a launch order for the Finnish version of VagiVital® from Orion Pharma. The value of the order is in excess of one million SEK, and it shall be delivered by the end of this year. -          This is another historical event in Peptonic. That Orion Pharma has decided to launch Peptonic’s non-prescription product for the treatment of vaginal dryness is an accolade to the clinical documentation and quality of the product, says Johan Inborr, CEO of Peptonic Medical. Soon

There are no items matching the current filter
There are no more items matching the current filter
Back to top